Can bioanalytical tools solve your neurodegenerative disease research challenges? 4 questions to ask yourself
Despite extensive efforts, neurodegenerative diseases (ND) continue to feel like a pharmaceutical frontier. We have…
Posts by NanoTemper Technologies
3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs
A caveat to a successful pharmaceutical industry in which many effective drugs have already been…
How Amgen looks at stability characterization to boost the success of biologics candidates
Biologic drugs have been incredibly successful in terms of both medical achievement and profitability. Many…
What to consider before accepting an offer to start your lab
Starting your own lab is a very exciting and rewarding opportunity. And, even if you…
How to convince researchers to join your new lab (over more established ones)
Starting a new lab as a principal investigator is an exhilarating endeavor. However, you’re met…
A guide to drafting an all-star team for your lab
As a new principal investigator, you now have a leadership role, guiding your lab members…
Characterize the true nature of intrinsically disordered proteins without immobilizing them
If you study neurodegenerative diseases (ND), you already know they are one of the most…
NanoTemper Technologies launches DLS capability with Prometheus Panta, bringing high-resolution, domain-specific stability characterization to biologics
Prometheus, the new gold standard, now provides clarity to the most challenging stability characterizations
Seven tips to give your grant proposal that extra edge
Grant writing is an important bread-and-butter skill that all principal investigators must develop, as this…